Monday, June 05, 2023 3:25:44 PM
Dear Stockholder:
This Information Statement is furnished to holders of shares of common stock, par value $0.001 per share (the “Common Stock”), of Decentral Life, Inc. (p/k/a Social Life Network, Inc.) (the “Company”). On the Effective Date of May 31, 2023, the Company’s Board of Directors (the “Board”) completed the approval, and recommended the approval by our stockholders by majority consent vote, of the following corporate action (the “Corporate Action”):
To approve an amendment to the Company’s Articles of Incorporation providing for the approval of a reverse stock split of our issued and outstanding shares of Common Stock at a range of 100 to 1 and 50,000 to 1 (the “Reverse Stock Split) at the sole discretion of the Board within 24 months from the date of the Board Resolution approving the Reverse Stock Split.
One of our stockholders, holding over 51% of our voting power on May 31, 2023 (the “Record Date”), approved the Corporate Action by written consent in lieu of a special meeting of stockholders.
All my post are my opinion. I don't give out buy or sell advice. Buy stocks at your own risk.
Recent WDLF News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 10:26:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 11:03:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:57:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 12:50:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 02:00:10 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 12/08/2023 06:16:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 05:41:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 08:13:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 10:05:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 08:05:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 08:52:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 01:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 01:00:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 06:57:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 09:25:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 12:00:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/14/2023 08:57:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:39:16 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM